YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

YS Biopharma Co Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

YS Biopharma Co Ltd
Total Liabilities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
YS Biopharma Co Ltd
NASDAQ:LSB
Total Liabilities
ÂĄ927.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Liabilities
ÂĄ16B
CAGR 3-Years
13%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Liabilities
ÂĄ7.9B
CAGR 3-Years
20%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Liabilities
ÂĄ3B
CAGR 3-Years
47%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Liabilities
ÂĄ23.3B
CAGR 3-Years
32%
CAGR 5-Years
39%
CAGR 10-Years
62%
Imeik Technology Development Co Ltd
SZSE:300896
Total Liabilities
ÂĄ504.4m
CAGR 3-Years
72%
CAGR 5-Years
51%
CAGR 10-Years
N/A

See Also

What is YS Biopharma Co Ltd's Total Liabilities?
Total Liabilities
927.8m CNY

Based on the financial report for Mar 31, 2024, YS Biopharma Co Ltd's Total Liabilities amounts to 927.8m CNY.

What is YS Biopharma Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 1Y
-6%

Over the last year, the Total Liabilities growth was -6%.

Back to Top